Cargando…
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight
BACKGROUND: Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells currently tested for multiple therapeutic purposes. Their potential to home into tumors, to secrete trophic/vasculogenic factors, and to suppress immune response raises questions regarding their biosafety. Our aim...
Autores principales: | Bruna, Flavia, Plaza, Anita, Arango, Martha, Espinoza, Iris, Conget, Paulette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948822/ https://www.ncbi.nlm.nih.gov/pubmed/29751770 http://dx.doi.org/10.1186/s13287-018-0878-1 |
Ejemplares similares
-
Regenerative Potential of Mesenchymal Stromal Cells: Age-Related Changes
por: Bruna, Flavia, et al.
Publicado: (2016) -
Omental adipose tissue is a more suitable source of canine Mesenchymal stem cells
por: Bahamondes, Francisca, et al.
Publicado: (2017) -
The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice
por: de Mayo, Tomas, et al.
Publicado: (2017) -
Techniques for Precancerous Lesion Diagnosis
por: Mendes, Sarah Freygang, et al.
Publicado: (2011) -
Precancerous Lesions in Colorectal Cancer
por: Sandouk, Fayez, et al.
Publicado: (2013)